Page last updated: 2024-11-05

theobromine and Overweight

theobromine has been researched along with Overweight in 1 studies

Theobromine: 3,7-Dimethylxanthine. The principle alkaloid in Theobroma cacao (the cacao bean) and other plants. A xanthine alkaloid that is used as a bronchodilator and as a vasodilator. It has a weaker diuretic activity than THEOPHYLLINE and is also a less powerful stimulant of smooth muscle. It has practically no stimulant effect on the central nervous system. It was formerly used as a diuretic and in the treatment of angina pectoris and hypertension. (From Martindale, The Extra Pharmacopoeia, 30th ed, pp1318-9)
theobromine : A dimethylxanthine having the two methyl groups located at positions 3 and 7. A purine alkaloid derived from the cacao plant, it is found in chocolate, as well as in a number of other foods, and is a vasodilator, diuretic and heart stimulator.

Overweight: A status with BODY WEIGHT that is above certain standards. In the scale of BODY MASS INDEX, overweight is defined as having a BMI of 25.0-29.9 kg/m2. Overweight may or may not be due to increases in body fat (ADIPOSE TISSUE), hence overweight does not equal over fat.

Research Excerpts

ExcerptRelevanceReference
"In a randomized, double-blind crossover study, 44 apparently healthy overweight (N = 30) and obese (N = 14) men and women with low HDL-C concentrations, consumed daily 500 mg theobromine or placebo for 4 weeks."9.30Theobromine consumption does not improve fasting and postprandial vascular function in overweight and obese subjects. ( Joris, PJ; Mensink, RP; Plat, J; Smolders, L; van den Driessche, JJ, 2019)
"In a randomized, double-blind crossover study, 44 apparently healthy overweight (N = 30) and obese (N = 14) men and women with low HDL-C concentrations, consumed daily 500 mg theobromine or placebo for 4 weeks."5.30Theobromine consumption does not improve fasting and postprandial vascular function in overweight and obese subjects. ( Joris, PJ; Mensink, RP; Plat, J; Smolders, L; van den Driessche, JJ, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Smolders, L1
Mensink, RP1
van den Driessche, JJ1
Joris, PJ1
Plat, J1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Effects of Short-term Theobromine Supplementation on Vascular Function and Intestinal apoA-I Production in Fasting and in the Postprandial State[NCT02209025]48 participants (Actual)Interventional2014-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for theobromine and Overweight

ArticleYear
Theobromine consumption does not improve fasting and postprandial vascular function in overweight and obese subjects.
    European journal of nutrition, 2019, Volume: 58, Issue:3

    Topics: Aged; Blood Pressure; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Fasting; Femal

2019